30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Netherlands Biotechnology & Medical Research

TME Pharma NV (ALTME)

Track

The most recent insider trading activity occurred on September 25, 2025, with a BUY transaction by the Managing Director/Chief Executive Officer, van den Ouden DM, for 135,000 shares valued at $13,500. This follows a series of BUY transactions by the same executive in the preceding days. Earlier, on December 16, 2024, another BUY transaction was made by Managing Director/CEO A.A. Mangasarian.
Stock chart
Ticker: ALTME Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
van den Ouden DM
Managing Director / Chief Executive Officer
1 purchase — total 13,500 EUR
Buy 25 Sep 2025
Value €2,157,940.70 | Price 320.98 | Shares 48,481
Buy 24 Sep 2025
Value €3,076,167.81 | Price 45.54 | Shares 33,592
Buy 23 Sep 2025
Value €3,000.00 | Price 0.10 | Shares 30,000
Buy 22 Sep 2025
Value €9,500.00 | Price 0.10 | Shares 95,000
Buy 19 Sep 2025
Value €27,000.00 | Price 0.09 | Shares 300,000
Buy 16 Dec 2024
Value €20,000.00 | Price 0.05 | Shares 400,000
Buy 9 Jul 2024
Value €12,750.00 | Price 0.15 | Shares 85,000
Buy 8 Jul 2024
Value €6,000.00 | Price 0.15 | Shares 40,000
Buy 7 Feb 2024
Value €80,000.14 | Price 0.22 | Shares 363,637
Buy 5 Dec 2023
Value €40,000.00 | Price 0.25 | Shares 160,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-02 2025-09-25 B Purchase
1.3
van den Ouden DM

Managing Director / Chief Executive Officer

Director
48,481
320.98
€2,157,941 		48,481 320.98 €2,157,941
2025-10-02 2025-09-24 B Purchase
1.3
van den Ouden DM

Managing Director / Chief Executive Officer

Director
33,592
45.54
€3,076,168 		33,592 45.54 €3,076,168
2025-10-02 2025-09-23 B Purchase
1.3
van den Ouden DM

Managing Director / Chief Executive Officer

Director
22,153
123.89
€610,169 		22,153 123.89 €610,169
2025-10-02 2025-09-22 B Purchase
1.3
van den Ouden DM

Managing Director / Chief Executive Officer

Director
95,000
0.10
€9,500 		95,000 0.10 €9,500
2025-09-25 2025-09-19 B Purchase
1.3
Ouden, van den

Managing Director / Chief Executive Director

Director
300,000
0.09
€27,000 		300,000 0.09 €27,000
2024-12-16 2024-12-16 B Purchase
2.8
Mangasarian A.A.

Managing Director / Chief Executive Officer

Director
400,000
0.05
€20,000 		400,000 0.05 €20,000
2024-07-13 2024-07-09 B Purchase
2.8
Mangasarian A.A.

Managing Director / Chief Executive Director

Director
85,000
0.15
€12,750 		85,000 0.15 €12,750
2024-07-13 2024-07-08 B Purchase
2.8
Mangasarian A.A.

Managing Director / Chief Executive Director

Director
40,000
0.15
€6,000 		40,000 0.15 €6,000
2024-02-07 2024-02-07 B Purchase
2.8
Mangasarian A.A.

Managing Director/Chief Executive Officer

Director
363,637
0.22
€80,000 		363,637 0.22 €80,000
2023-12-05 2023-12-05 B Purchase
2.8
Mangasarian A.A.

Managing Director / Chief Executive Officer

Director
160,000
0.25
€40,000 		160,000 0.25 €40,000
Explore more

More insider trading research around TME Pharma NV

More insider trades in Netherlands
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe